Search global stocks & ETFs...Ctrl K

Learn Mode

BDX - Becton Dickinson and Co

87

$149.31

$0.27 (0.181%)

At market close

$149.33

$0.02 (0.010%)

After Hours 5/1/26, 8:49 PM

Score

3.37/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

BDX

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$42.51B

Industry

Health Care

EPS (TTM)

$6.14

P/E (TTM)

24.20

Div & Yield

$4.20 (2.81%)

FCF Payout Ratio

45.45%

P/S (TTM)

1.94

P/B

1.68

Diluted Shares

285.85M

Ex-Dividend

2026-03-10

Next Earnings

05-07

Forward P/E

11.26

Payout Ratio

68.07%

P/FCF (TTM)

16.16

FCF Yield

6.19%

Earnings Yield

4.13%

52 Week Range

Score Card

Explore Scores Tab

3.37

Average

Becton Dickinson and Co has grown revenue at 6.22% over the past year, which suggests sales are increasing. Also, it has seen its diluted average shares outstanding decrease by -1.56% over the past year, which suggests the company is buying back shares.

Valuation Model

Key Score

5.00

Very Good

Management

2.00

Bad

Growth

1.00

Very Bad

Profitability

1.00

Very Bad

Fin. Health

2.00

Bad

Dividends

3.00

Average

Analyst

4.00

Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

5 new filings were in the last 7 days

Filter Form Types

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-04-29 17:12:18

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-29 16:16:44

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-04-29 12:23:58

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-28 07:44:18

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-04-27 16:34:11

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-09 16:18:47

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-06 17:28:51

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-02 16:18:23

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-27 13:49:58

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-03-26 16:24:04

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-26 16:07:48

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 14:46:24

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-04-25

High:

$237.64

59.2%

Avg:

$198.14

32.7%

Low:

$158.57

6.2%

(% change is relative to the current stock price: $149.31)

Analyst Recommendations

Go to Analyst Tab

3.70

Good

25%

Strong Buy (5)

20%

Buy (4)

55%

Hold (11)

Sell (0)

Strong Sell (0)

About

Website
https://www.bd.com/
Address
One Becton Drive, Franklin Lakes NEW JERSEY, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=10795

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.

IPO Date

1963-09-25

Industry

Health Care

Total Employees

72,000

Exchange

New York Stock Exchange, Inc.

Reporting Currency

USD

GICS

Health Care Equipment & Supplies

GICS Sub

Health Care Equipment

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services

BDX - Becton Dickinson and Co

87

$149.31

$0.27 (0.181%)

$149.33

$0.02 (0.010%)

3.37/5

Stock Unlock

Stock Profile

Score Card

Average

Insider Transactions

Market News

Form SCHEDULE 13G

Filed on 2026-04-29 17:12:18

Form 8-K

Filed on 2026-04-29 16:16:44

Form SCHEDULE 13G

Filed on 2026-04-29 12:23:58

Form 4

Filed on 2026-04-28 07:44:18

Form 144

Filed on 2026-04-27 16:34:11

Form 8-K

Filed on 2026-04-09 16:18:47

Form 4

Filed on 2026-04-06 17:28:51

Form 8-K

Filed on 2026-04-02 16:18:23

Form 4

Filed on 2026-03-27 13:49:58

Form 144

Filed on 2026-03-26 16:24:04

Form SCHEDULE 13G/A

Filed on 2026-03-26 16:07:48

Form 4

Filed on 2026-03-17 14:46:24

Financials

Price Targets

59.2%

32.7%

6.2%

Analyst Recommendations

About

Similar Stocks